However, because the “PD-1–PD-L1 axis” and CTLA-4 pathway also mediate autoimmune damage, (Johnson et al., 2016; Varricchi et al., 2017a), ICIs can activate lymphocytes and macrophages to infiltrate nontumor as well as tumor tissues. Here, CD274 is linked to neoplasm.